Whalesbook
Dekho bhai, May 11, 2026 ko Indian equity markets mein tohofan aa gaya. Nifty 50 close hua 23,815.85 par, jo ki 1.49% kam tha. Ye sab geopolitical tensions aur crude oil ke badhte prices ki wajah se hua. Lekin is sab mein bhi, healthcare aur pharma sector ne apni jagah banaye rakhi aur investors ko relief diya.
Hmm, toh healthcare sector toh waise hi champion nikla, 0.61% badh gaya jab Nifty 50 aur Sensex March ke baad sabse zyada gire. Max Healthcare Institute 2.72% bhaga aur ₹1,040 par pahunch gaya. Sun Pharma bhi thoda upar aaya. Narayana Hrudayalaya ₹1,886.4 ke aas paas trade kar raha tha, jiska P/E lagbhag 47.55 aur market cap ₹38,550 Crore hai. Fortis Healthcare aur Laurus Labs bhi acche technical indicators dikha rahe the, jo batata hai ki inmein investor interest bana hua hai.
Abhi kya hai na, healthcare companies ke P/E ratios kaafi high chal rahe hain, unke defensive nature ya strong growth prospects ki wajah se. Max Healthcare Institute ka P/E lagbhag 69 hai aur Fortis Healthcare ka 74.39 (TTM basis par 432.69). Fortis ka market cap ₹70,600 Crore se zyada hai, aur Laurus Labs ka bhi ₹66,378 Crore ke aas paas hai. Iske bawajood, analysts abhi bhi positive hain. Fortis Healthcare ke liye average 'Buy' rating hai aur target price ₹1,076.61 diya hai. Narayana Hrudayalaya ko bhi long term ke liye 'Buy' recommend kiya gaya hai. Matlab market in sectors ko stable aur reliable maanta hai.
Nifty Pharma index bhi 0.22% upar tha, jo dikhata hai ki pharma sector ne bhi achha kiya, jabki Realty aur Consumer Durables sector mein kafi selling hui. Ye normally hota hai jab economy mein uncertainty hoti hai. Lekin sab kuch itna bhi smooth nahi hai. Itne high P/E ratios par kuch companies ko overvalued bhi mana ja sakta hai. Agar geopolitical tensions kam hui ya oil prices stable hue, toh investors defensive stocks se nikal kar cyclical stocks mein ja sakte hain, jisse sharp correction aa sakta hai. Pharma companies ko international pricing aur drug approvals se bhi challenges aa sakti hain. Kuch specific stocks jaise Eternal ko toh sell karne ki warning bhi mili hai, isliye sabko dhyan dena chahiye.
Aage kya hoga ye sab Middle East ke events, crude oil prices aur Indian Rupee par depend karega. Healthcare jaise defensive sectors mein paisa aa sakta hai, lekin overall market abhi cautious hi rahega. Investors abhi earnings reports ka intezar kar rahe hain, khas kar oil and gas aur pharma companies se. Healthcare companies ko apne earnings growth aur operational efficiency maintain karni hogi, warna current valuations ko support karna mushkil ho jayega.